0001752724-22-097757.txt : 20220429 0001752724-22-097757.hdr.sgml : 20220429 20220429093920 ACCESSION NUMBER: 0001752724-22-097757 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220228 FILED AS OF DATE: 20220429 PERIOD START: 20221130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Natixis Funds Trust II CENTRAL INDEX KEY: 0000052136 IRS NUMBER: 041990692 STATE OF INCORPORATION: MA FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-00242 FILM NUMBER: 22870898 BUSINESS ADDRESS: STREET 1: 888 BOYLSTON STREET STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 800-283-1155 MAIL ADDRESS: STREET 1: 888 BOYLSTON STREET STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 FORMER COMPANY: FORMER CONFORMED NAME: IXIS Advisor Funds Trust II DATE OF NAME CHANGE: 20050502 FORMER COMPANY: FORMER CONFORMED NAME: CDC NVEST FUNDS TRUST II DATE OF NAME CHANGE: 20010503 FORMER COMPANY: FORMER CONFORMED NAME: NVEST FUNDS TRUST II DATE OF NAME CHANGE: 20000202 0000052136 S000053353 Loomis Sayles Global Growth Fund C000167848 Class A LSAGX C000167849 Class C LSCGX C000167850 Class Y LSGGX C000188122 Class N LSNGX NPORT-P 1 primary_doc.xml NPORT-P false 0000052136 XXXXXXXX S000053353 C000167848 C000167849 C000167850 C000188122 Natixis Funds Trust II 811-00242 0000052136 R4B5ZXLI2IMIOWT67V76 888 BOYLSTON STREET Suite 800 BOSTON 02199-8197 617-449-2810 Loomis Sayles Global Growth Fund S000053353 5493008W63EBOWG4HO71 2022-11-30 2022-02-28 N 115700221.47 285485.24 115414736.23 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 N salesforce.com Inc RCGZFPDMRW58VJ54VR07 salesforce.com Inc 79466L302 16249.00000000 NS USD 3420901.97000000 2.964007960978 Long EC CORP US N 1 N N N Alnylam Pharmaceuticals Inc 529900S3ZI14OWRJII50 Alnylam Pharmaceuticals Inc 02043Q107 19925.00000000 NS USD 3145161.25000000 2.725095037892 Long EC CORP US N 1 N N N Expeditors International of Washington Inc 984500B055A804AB6E40 Expeditors International of Washington Inc 302130109 9350.00000000 NS USD 966416.00000000 0.837341947456 Long EC CORP US N 1 N N N Vertex Pharmaceuticals Inc 54930015RAQRRZ5ZGJ91 Vertex Pharmaceuticals Inc 92532F100 9134.00000000 NS USD 2101002.68000000 1.820393780403 Long EC CORP US N 1 N N N Schlumberger NV 213800ZUA17OK3QLGM62 Schlumberger NV 806857108 15959.00000000 NS USD 626231.16000000 0.542592029801 Long EC CORP CW N 1 N N N Core Laboratories NV 724500MDYY5VBSAF5W50 Core Laboratories NV 000000000 3887.00000000 NS USD 107125.72000000 0.092818060760 Long EC CORP NL N 1 N N N Novo Nordisk A/S 549300DAQ1CVT6CXN342 Novo Nordisk A/S 000000000 15563.00000000 NS 1610512.21000000 1.395412979838 Long EC CORP DK N 2 N N N Under Armour Inc 549300D4549QKWETZ406 Under Armour Inc 904311107 103638.00000000 NS USD 1854083.82000000 1.606453283664 Long EC CORP US N 1 N N N Reckitt Benckiser Group PLC 5493003JFSMOJG48V108 Reckitt Benckiser Group PLC 000000000 6244.00000000 NS 528723.80000000 0.458107705541 Long EC CORP GB N 2 N N N Alphabet Inc 5493006MHB84DD0ZWV18 Alphabet Inc 02079K305 2738.00000000 NS USD 7395721.32000000 6.407952365165 Long EC CORP US N 1 N N N Visa Inc 549300JZ4OKEHW3DPJ59 Visa Inc 92826C839 24399.00000000 NS USD 5273111.88000000 4.568837613155 Long EC CORP US N 1 N N N Sodexo SA 969500LCBOG12HXPYM84 Sodexo SA 000000000 11251.00000000 NS 939309.25000000 0.813855561847 Long EC CORP FR N 2 N N N Roche Holding AG 549300U41AUUVOAAOB37 Roche Holding AG 000000000 11666.00000000 NS 4418302.90000000 3.828196506202 Long EC CORP CH N 2 N N N Alibaba Group Holding Ltd 5493001NTNQJDH60PM02 Alibaba Group Holding Ltd 01609W102 14196.00000000 NS USD 1493277.24000000 1.293835855608 Long EC CORP KY N 1 N N N NXP Semiconductors NV 724500M9BY5293JDF951 NXP Semiconductors NV 000000000 14361.00000000 NS USD 2730313.32000000 2.365653996348 Long EC CORP NL N 1 N N N Microsoft Corp INR2EJN1ERAN0W5ZP974 Microsoft Corp 594918104 17706.00000000 NS USD 5290375.74000000 4.583795720381 Long EC CORP US N 1 N N N Adyen NV 724500973ODKK3IFQ447 Adyen NV 000000000 2154.00000000 NS 4489522.48000000 3.889904033617 Long EC CORP NL N 2 N N N CRISPR Therapeutics AG 506700O6IRRIQLT3W370 CRISPR Therapeutics AG 000000000 33997.00000000 NS USD 2086395.89000000 1.807737866196 Long EC CORP CH N 1 N N N Nestle SA KY37LUS27QQX7BB93L28 Nestle SA 000000000 17361.00000000 NS 2262063.98000000 1.959943811240 Long EC CORP CH N 2 N N N Netflix Inc 549300Y7VHGU0I7CE873 Netflix Inc 64110L106 5710.00000000 NS USD 2252709.20000000 1.951838451123 Long EC CORP US N 1 N N N Unilever PLC 549300MKFYEKVRWML317 Unilever PLC 000000000 30858.00000000 NS 1548284.48000000 1.341496355296 Long EC CORP GB N 2 N N N FANUC Corp 529900QTSW745LOKW705 FANUC Corp 000000000 15200.00000000 NS 2792271.87000000 2.419337392441 Long EC CORP JP N 2 N N N Fixed Income Clearing Corp 549300H47WTHXPU08X20 FIXED INC CLEARING CORP.REPO 000000000 925802.67000000 PA USD 925802.67000000 0.802152914126 Long RA CORP US N 2 Repurchase N 0.00000000 2022-03-01 943800.00000000 USD 944389.88000000 USD UST N N N Yum China Holdings Inc 529900DO9BYZ7VA3K502 Yum China Holdings Inc 98850P109 36551.00000000 NS USD 1901383.02000000 1.647435225438 Long EC CORP US N 1 N N N JD.com Inc 549300HVTWB0GJZ16V92 JD.com Inc 000000000 3104.00000000 NS 110873.08000000 0.096064925174 Long EC CORP KY N 2 N N N Budweiser Brewing Co APAC Ltd 549300YF1MR4GTF18132 Budweiser Brewing Co APAC Ltd 000000000 195232.00000000 NS 605994.17000000 0.525057882376 Long EC CORP KY N 2 N N N Ambev SA 549300TH5Q6VRP8OT012 Ambev SA 02319V103 977627.00000000 NS USD 2864447.11000000 2.481872942369 Long EC CORP BR N 1 N N N Trip.com Group Ltd 2549004RMYDSRQL4KW41 Trip.com Group Ltd 89677Q107 65206.00000000 NS USD 1683618.92000000 1.458755593085 Long EC CORP KY N 1 N N N Deere & Co PWFTNG3EI0Y73OXWDH08 Deere & Co 244199105 5741.00000000 NS USD 2066874.82000000 1.790824020843 Long EC CORP US N 1 N N N Meta Platforms Inc BQ4BKCS1HXDV9HN80Z93 Meta Platforms Inc 30303M102 19984.00000000 NS USD 4217223.52000000 3.653973190733 Long EC CORP US N 1 N N N Oracle Corp 1Z4GXXU7ZHVWFCD8TV52 Oracle Corp 68389X105 57388.00000000 NS USD 4359766.36000000 3.777478078112 Long EC CORP US N 1 N N N Experian PLC 635400RXXHHYT1JTSZ26 Experian PLC 000000000 72686.00000000 NS 2839438.39000000 2.460204374891 Long EC CORP JE N 2 N N N Boeing Co/The RVHJWBXLJ1RFUBSY1F30 Boeing Co/The 097023105 24314.00000000 NS USD 4992636.76000000 4.325822614237 Long EC CORP US N 1 N N N Autodesk Inc FRKKVKAIQEF3FCSTPG55 Autodesk Inc 052769106 7252.00000000 NS USD 1597107.96000000 1.383798994971 Long EC CORP US N 1 N N N Baidu Inc 254900AL64IANZYI1E02 Baidu Inc 056752108 14341.00000000 NS USD 2186142.04000000 1.894161968748 Long EC CORP KY N 1 N N N Yum! Brands Inc 549300JE8XHZZ7OHN517 Yum! Brands Inc 988498101 7259.00000000 NS USD 889808.22000000 0.770965865421 Long EC CORP US N 1 N N N QUALCOMM Inc H1J8DDZKZP6H7RWC0H53 QUALCOMM Inc 747525103 16199.00000000 NS USD 2786066.01000000 2.413960384095 Long EC CORP US N 1 N N N MercadoLibre Inc 549300DKPDN9M5S8GB14 MercadoLibre Inc 58733R102 4865.00000000 NS USD 5481152.25000000 4.749092212173 Long EC CORP US N 1 N N N Novartis AG 5493007HIVTX6SY6XD66 Novartis AG 000000000 61798.00000000 NS 5431512.67000000 4.706082470418 Long EC CORP CH N 2 N N N Tencent Holdings Ltd 254900N4SLUMW4XUYY11 Tencent Holdings Ltd 000000000 66200.00000000 NS 3572238.81000000 3.095132325980 Long EC CORP KY N 2 N N N Colgate-Palmolive Co YMEGZFW4SBUSS5BQXF88 Colgate-Palmolive Co 194162103 6433.00000000 NS USD 495019.35000000 0.428904805547 Long EC CORP US N 1 N N N Amazon.com Inc ZXTILKJKG63JELOEG630 Amazon.com Inc 023135106 2557.00000000 NS USD 7853211.82000000 6.804340655728 Long EC CORP US N 1 N N N SEI Investments Co 5LJTIFADGZ6XH1RVOC11 SEI Investments Co 784117103 20255.00000000 NS USD 1186537.90000000 1.028064473184 Long EC CORP US N 1 N N N 2022-03-30 Natixis Funds Trust II John Sgroi John Sgroi Assistant Treasurer XXXX NPORT-EX 2 NPORT_IAL7_82843129_0222.htm FOR VALIDATION PURPOSES ONLY - [350270.IAL7]

PORTFOLIO OF INVESTMENTS – as of February 28, 2022 (Unaudited)

Loomis Sayles Global Growth Fund

 

    Shares    

    

Description

       Value (†)          
 

Common Stocks – 99.1% of Net Assets

 
  

Brazil – 7.2%

 

  977,627      Ambev S.A., ADR    $ 2,864,447  
  4,865      MercadoLibre, Inc.(a)      5,481,152  
     

 

 

 
        8,345,599  
     

 

 

 
  

China – 12.4%

 

  14,196      Alibaba Group Holding Ltd., Sponsored ADR(a)(b)      1,493,277  
  14,341      Baidu, Inc., Sponsored ADR(a)(b)      2,186,142  
  195,232      Budweiser Brewing Co. APAC Ltd., 144A      605,994  
  3,104      JD.com, Inc., Class A(a)      110,873  
  14,361      NXP Semiconductors NV      2,730,314  
  66,200      Tencent Holdings Ltd.(b)      3,572,239  
  65,206      Trip.com Group Ltd., ADR(a)(b)      1,683,619  
  36,551      Yum China Holdings, Inc.      1,901,383  
     

 

 

 
        14,283,841  
     

 

 

 
  

Denmark – 1.4%

 

  15,563      Novo Nordisk A/S, Class B      1,610,512  
     

 

 

 
  

France – 0.8%

 

  11,251      Sodexo S.A.      939,309  
     

 

 

 
  

Japan – 2.4%

 

  15,200      FANUC Corp.      2,792,272  
     

 

 

 
  

Netherlands – 3.9%

 

  2,154      Adyen NV, 144A(a)      4,489,523  
     

 

 

 
  

Switzerland – 12.3%

 

  33,997      CRISPR Therapeutics AG(a)      2,086,396  
  17,361      Nestle S.A., (Registered)      2,262,064  
  61,798      Novartis AG, (Registered)      5,431,512  
  11,666      Roche Holding AG      4,418,303  
     

 

 

 
        14,198,275  
     

 

 

 
  

United Kingdom – 4.3%

 

  72,686      Experian PLC      2,839,438  
  6,244      Reckitt Benckiser Group PLC      528,724  
  30,858      Unilever PLC      1,548,285  
     

 

 

 
        4,916,447  
     

 

 

 
  

United States – 54.4%

 

  19,925      Alnylam Pharmaceuticals, Inc.(a)      3,145,161  
  2,738      Alphabet, Inc., Class A(a)      7,395,721  
  2,557      Amazon.com, Inc.(a)      7,853,212  
  7,252      Autodesk, Inc.(a)      1,597,108  
  24,314      Boeing Co. (The)(a)      4,992,637  
  6,433      Colgate-Palmolive Co.      495,019  
  3,887      Core Laboratories NV      107,126  
  5,741      Deere & Co.      2,066,875  

        Shares         

    

Description

           Value (†)          
 

Common Stocks – continued

 
   United States – continued   
  9,350      Expeditors International of Washington, Inc.    $ 966,416  
  19,984      Meta Platforms, Inc., Class A(a)      4,217,223  
  17,706      Microsoft Corp.      5,290,376  
  5,710      Netflix, Inc.(a)      2,252,709  
  57,388      Oracle Corp.      4,359,766  
  16,199      QUALCOMM, Inc.      2,786,066  
  16,249      salesforce.com, Inc.(a)      3,420,902  
  15,959      Schlumberger NV      626,231  
  20,255      SEI Investments Co.      1,186,538  
  103,638      Under Armour, Inc., Class A(a)      1,854,084  
  9,134      Vertex Pharmaceuticals, Inc.(a)      2,101,003  
  24,399      Visa, Inc., Class A      5,273,112  
  7,259      Yum! Brands, Inc.      889,808  
     

 

 

 
        62,877,093  
     

 

 

 
   Total Common Stocks
(Identified Cost $100,899,448)
     114,452,871  
     

 

 

 
Principal
Amount
             
 

Short-Term Investments – 0.8%

 
$ 925,803      Tri-Party Repurchase Agreement with Fixed Income Clearing Corporation, dated 2/28/2022 at 0.000% to be repurchased at $925,803 on 3/01/2022 collateralized by $943,800 U.S. Treasury Note, 1.875% due 2/28/2027 valued at $944,390 including accrued interest(c)
(Identified Cost $925,803)
     925,803  
     

 

 

 
   Total Investments – 99.9%
(Identified Cost $101,825,251)
     115,378,674  
   Other assets less liabilities – 0.1%      98,555  
     

 

 

 
   Net Assets – 100.0%    $ 115,477,229  
     

 

 

 
(†)

Fund securities and other investments are valued at market value based on market quotations obtained or determined by independent pricing services recommended by the adviser and approved by the Board of Trustees. Fund securities and other investments for which market quotations are not readily available are valued at fair value as determined in good faith by the adviser pursuant to procedures approved by the Board of Trustees, as described below. Market value is determined as follows:

 

    

Listed equity securities (including shares of closed-end investment companies and exchange-traded funds) are valued at the last sale price quoted on the exchange where they are traded most extensively or, if there is no reported sale during the day, the closing bid quotation as reported by an independent pricing service. Securities traded on the NASDAQ Global Select Market, NASDAQ Global Market and NASDAQ Capital Market are valued at the NASDAQ Official Closing Price (“NOCP”), or if lacking an NOCP, at the most recent bid quotations on the applicable NASDAQ Market. Unlisted equity securities (except unlisted preferred equity securities) are valued at the last sale price quoted in the market where they are traded most extensively or, if there is no reported sale during the day, the closing bid quotation as reported by an independent pricing service. If there is no last sale price or closing bid quotation available, unlisted equity securities will be valued using evaluated bids furnished by an independent pricing service, if available.

 

    

In some foreign markets, an official close price and a last sale price may be available from the foreign exchange or market. In those cases, the official close price is used.

 

    

Debt securities and unlisted preferred equity securities are valued based on evaluated bids furnished to the Fund by an independent pricing service or bid prices obtained from broker-dealers.

 

    

Broker-dealer bid prices may be used to value debt and unlisted equity securities where an independent pricing service is unable to price a security or where an independent pricing service does not provide a reliable price for the security.

 

    

Fund securities and other investments for which market quotations are not readily available are valued at fair value as determined in good faith by the adviser pursuant to procedures approved by the Board of Trustees. The Fund may also value securities and other investments at fair value in other circumstances such as when extraordinary events occur after the close of a foreign market but prior to the close of the New York Stock Exchange. This may include situations relating to a single issuer (such as a declaration of bankruptcy or a delisting of the issuer’s security from the primary market on which it has traded) as well as events affecting the securities markets in general (such as market disruptions or closings and significant fluctuations in U.S. and/or foreign markets). When fair valuing its securities or other investments, the Fund may, among other things, use modeling tools or other processes that may take into account factors such as securities or other market activity and/or significant events that occur after the close of the foreign market and before the time the Fund’s net asset value (“NAV”) is calculated. Fair value pricing may require subjective determinations about the value of a security, and fair values used to determine the Fund’s NAV may differ from quoted or published prices, or from prices that are used by others, for the same securities. In addition, the use of fair value pricing may not always result in adjustments to the prices of securities held by the Fund.

 

    

As of February 28, 2022, securities held by the Fund were fair valued as follows:

 

Equity
securities1
   Percentage of
Net Assets
$31,149,048    27.0%

 

1

Certain foreign equity securities were fair valued pursuant to procedures approved by the Board of Trustees as events occurring after the close of the foreign market were believed to materially affect the value of those securities.

 

    

The books and records of the Fund are maintained in U.S. dollars. The values of securities, currencies and other assets and liabilities denominated in currencies other than U.S. dollars are translated into U.S. dollars based upon foreign exchange rates prevailing at the end of the period.

(a)

Non-income producing security.

(b)

Security invests in variable interest entities based in China.

(c)

The Fund may enter into repurchase agreements, under the terms of a Master Repurchase Agreement, under which the Fund acquires securities as collateral and agrees to resell the securities at an agreed upon time and at an agreed upon price. It is the Fund’s policy that the market value of the collateral for repurchase agreements be at least equal to 102% of the repurchase price, including interest. Certain repurchase agreements are tri-party arrangements whereby the collateral is held in a segregated account for the benefit of the Fund and on behalf of the counterparty. Repurchase agreements could involve certain risks in the event of default or insolvency of the counterparty, including possible delays or restrictions upon the Fund’s ability to dispose of the underlying securities. As of February 28, 2022, the Fund had an investment in a repurchase agreement for which the value of the related collateral exceeded the value of the repurchase agreement.

 

144A

All or a portion of these securities are exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At February 28, 2022, the value of Rule 144A holdings amounted to $5,095,517 or 4.4% of net assets.

ADR

An American Depositary Receipt is a certificate issued by a custodian bank representing the right to receive securities of the foreign issuer described. The values of ADRs may be significantly influenced by trading on exchanges not located in the United States.

Fair Value Measurements

In accordance with accounting standards related to fair value measurements and disclosures, the Fund has categorized the inputs utilized in determining the value of the Fund’s assets or liabilities. These inputs are summarized in the three broad levels listed below:

 

   

Level 1 – quoted prices in active markets for identical assets or liabilities;

 

   

Level 2 – prices determined using other significant inputs that are observable either directly, or indirectly through corroboration with observable market data (which could include quoted prices for similar assets or liabilities, interest rates, credit risk, etc.); and

 

   

Level 3 – prices determined using significant unobservable inputs when quoted prices or observable inputs are unavailable such as when there is little or no market activity for an asset or liability (unobservable inputs reflect the Fund’s own assumptions in determining the fair value of assets or liabilities and would be based on the best information available).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

The following is a summary of the inputs used to value the Fund’s investments as of February 28, 2022, at value:

Asset Valuation Inputs

 

Description

   Level 1      Level 2      Level 3      Total  

Common Stocks

           

China

   $ 9,994,735      $ 4,289,106      $ —        $ 14,283,841  

Denmark

     —          1,610,512        —          1,610,512  

France

     —          939,309        —          939,309  

Japan

     —          2,792,272        —          2,792,272  

Netherlands

     —          4,489,523        —          4,489,523  

Switzerland

     2,086,396        12,111,879        —          14,198,275  

United Kingdom

     —          4,916,447        —          4,916,447  

All Other Common Stocks*

     71,222,692               —          71,222,692  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total Common Stocks

     83,303,823        31,149,048        —          114,452,871  
  

 

 

    

 

 

    

 

 

    

 

 

 

Short-Term Investments

     —          925,803        —          925,803  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 83,303,823      $ 32,074,851      $ —        $ 115,378,674  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

*

Details of the major categories of the Fund’s investments are reflected within the Portfolio of Investments.

Industry Summary at February 28, 2022 (Unaudited)

 

Interactive Media & Services

     15.1

Internet & Direct Marketing Retail

     12.9  

Software

     12.8  

Pharmaceuticals

     9.9  

IT Services

     8.5  

Biotechnology

     6.3  

Semiconductors & Semiconductor Equipment

     4.8  

Hotels, Restaurants & Leisure

     4.7  

Aerospace & Defense

     4.3  

Machinery

     4.2  

Beverages

     3.0  

Professional Services

     2.5  

Food Products

     2.0  

Other Investments, less than 2% each

     8.1  

Short-Term Investments

     0.8  
  

 

 

 

Total Investments

     99.9  

Other assets less liabilities

     0.1  
  

 

 

 

Net Assets

     100.0
  

 

 

 

Currency Exposure Summary at February 28, 2022 (Unaudited)

 

United States Dollar

     72.9

Swiss Franc

     10.5  

Euro

     6.0  

Hong Kong Dollar

     3.7  

British Pound

     3.0  

Japanese Yen

     2.4  

Danish Krone

     1.4  
  

 

 

 

Total Investments

     99.9  

Other assets less liabilities

     0.1  
  

 

 

 

Net Assets

     100.0